Literature DB >> 19595889

Aggressive course of disease in dementia.

Serge Gauthier1, Bruno Vellas, Martin Farlow, David Burn.   

Abstract

The rate of disease progression in Alzheimer's disease (AD) patients is variable. A significant proportion of AD patients appear to experience an aggressive course of disease, and this has a major impact on prognosis, the patients, and their caregivers and society in general. Here we review the current literature on an aggressive course of disease in dementia and how it can be recognized in clinical practice. We also discuss the options available for treating patients with this condition.

Entities:  

Year:  2006        PMID： 19595889     DOI： 10.1016/j.jalz.2006.03.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN： 1552-5260            Impact factor:   21.566


  12 in total

1.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  Cerebrospinal fluid β-amyloid 1-42 correlates with rate of progression in Alzheimer's disease.

Authors:  George S Vlachos; George P Paraskevas; Dimitris Naoumis; Elizabeth Kapaki
Journal:  J Neural Transm (Vienna)       Date:  2012-03-30       Impact factor: 3.575

3.  Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire.

Authors:  L Carcaillon; G Berrut; F Sellal; J F Dartigues; S Gillette; J J Pere; I Bourdeix
Journal:  J Nutr Health Aging       Date:  2011-05       Impact factor: 4.075

4.  Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.

Authors:  Steven Ferris; Agneta Nordberg; Hilkka Soininen; Taher Darreh-Shori; Roger Lane
Journal:  Pharmacogenet Genomics       Date:  2009-08       Impact factor: 2.089

5.  The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.

Authors:  Florindo Stella; Orestes Vicente Forlenza; Jerson Laks; Larissa Pires de Andrade; Michelle A Ljubetic Avendaño; Elisandra Villela Gasparetto Sé; João de Castilho Cação; Constantine G Lyketsos; Kate de Medeiros
Journal:  Int Psychogeriatr       Date:  2013-06-14       Impact factor: 3.878

6.  Predictors of long-term cognitive outcome in Alzheimer's disease.

Authors:  Carina Wattmo; Asa K Wallin; Elisabet Londos; Lennart Minthon
Journal:  Alzheimers Res Ther       Date:  2011-07-20       Impact factor: 6.982

7.  The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database.

Authors:  Maowen Ba; Xiaofeng Li; Kok Pin Ng; Tharick A Pascoal; Sulantha Mathotaarachchi; Pedro Rosa-Neto; Serge Gauthier
Journal:  Alzheimers Dement (N Y)       Date:  2017-02-09

8.  Cognitive and affective assessment in day care versus institutionalized elderly patients: a 1-year longitudinal study.

Authors:  Ana Maseda; Aránzazu Balo; Laura Lorenzo-López; Leire Lodeiro-Fernández; José Luis Rodríguez-Villamil; José Carlos Millán-Calenti
Journal:  Clin Interv Aging       Date:  2014-06-05       Impact factor: 4.458

9.  Apathy in Alzheimer's disease: Contribution to a clinical view on progression of dementia.

Authors:  Florindo Stella; Larissa Pires de Andrade; Thays Martins Vital; Flávia Gomes de Melo Coelho; Carla Manuela Crispim Nascimento; Salma Stephany Soleman Hernández
Journal:  Dement Neuropsychol       Date:  2010 Jul-Sep

10.  Longitudinal cognitive screening study in community-dwelling individuals.

Authors:  Carolina P M Pereira; Florindo Stella; Salma S S Hernandez; Larissa P Andrade; Camila V L Texeira; Sebastião Gobbi
Journal:  Dement Neuropsychol       Date:  2010 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.